<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="121168">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02102971</url>
  </required_header>
  <id_info>
    <org_study_id>201400182</org_study_id>
    <secondary_id>R01DK079879</secondary_id>
    <nct_id>NCT02102971</nct_id>
  </id_info>
  <brief_title>Observational Study of Biomarker During Liver Surgery</brief_title>
  <official_title>Autophagy in Liver Injury: Changes in Autophagy Biomarkers During Liver Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators would like to study whether Sirtuin 1 (SIRT1) plays a cytoprotective role
      in liver ischemia/reperfusion, and ultimately to develop therapeutic strategies to improve
      hepatic function of patients with liver diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      If asked to participate in this research study, it is because a liver resection/liver
      transplantation surgery has been scheduled. During the procedure a small section will be
      collected for additional testing of Sirtuin 1. In addition, information concerning the liver
      disease, laboratory and pathology results after surgery will be collected by the
      investigators.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Biochemical analysis of sirtuin1 from liver tissues during liver surgery</measure>
    <time_frame>30 minutes during liver surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Liver Cancer</condition>
  <condition>Hepatobiliary Tract Adenomas and Carcinomas</condition>
  <arm_group>
    <arm_group_label>Hepatocellular carcinoma</arm_group_label>
    <description>Participants undergoing a liver resection/liver transplantation surgery. During the liver surgery a small piece of tissue will be removed to undergo additional laboratory testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hepatocellular carcinoma</intervention_name>
    <description>Participants undergoing a liver resection/liver transplantation surgery. During the liver surgery a small piece of tissue will be removed to undergo additional laboratory testing.</description>
    <arm_group_label>Hepatocellular carcinoma</arm_group_label>
    <other_name>Liver resection</other_name>
    <other_name>Liver transplantation sugery</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      liver tissues during liver surgery
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Liver Disease Requring Liver Resection Surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  liver resection &gt; 2 segments,

          -  plate count &gt; 100 x 109/L, and

          -  prothrombin activity &gt;60%.

        Exclusion Criteria:

          -  liver cirrhosis,

          -  portal hypertension,

          -  steatohepatitis or severe steatosis,

          -  patients receiving additional ablation therapies,

          -  laparoscopic resection, and

          -  simultaneous extrahepatic procedures such as colorectal resection or
             pancreatoduodenectomy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae-Sung Kim, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jae-Sung Kim, PhD</last_name>
    <phone>352-392-7461</phone>
    <email>jae.kim@surgery.ufl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UF Health</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jae-Sung Kim, PhD</last_name>
      <phone>352-392-7461</phone>
      <email>jae.kim@surgery.ufl.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 2, 2014</lastchanged_date>
  <firstreceived_date>March 31, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver</keyword>
  <keyword>ischemia</keyword>
  <keyword>reperfusion</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
